Back to Macquarie Group Ltd. Macquarie Group Ltd.

NTLANTLA

Showing 6 of 25 quarters

Position history for Macquarie Group Ltd.Macquarie Group Ltd.'s holdings in Intellia Therapeutics, Inc.

No. Macquarie Group exited its NTLA (Intellia Therapeutics) position in Q4 2025. Its Q3 2025 13F listed 20,000 shares worth $345,000. Macquarie Group already held NTLA in its Q4 2018 13F, the earliest on record, and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$411,000

Total Shares Change

-20,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$8.99
0
2025-Q3
Unchanged
20,000
0.0%
$345,0000.0%$17.27
0
2025-Q2
Unchanged
20,000
0.0%
$188,0000.0%$9.38
0
2025-Q1
Unchanged
20,000
0.0%
$142,0000.0%$7.11
0
2024-Q4
Unchanged
20,000
0.0%
$233,0000.0%$11.66
0
2024-Q3
Unchanged
20,000
0.0%
$411,0000.0%$20.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used